[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100362504":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":33,"locations":42,"responsibleParty":60,"collaborators":10,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":64,"sex":68,"minAge":69,"maxAge":10,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":10,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"University Hospital, Basel, Switzerland","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"acute coronary syndrome (ACS)",null,"Outcome information (all-cause death, heart failure (HF) hospitalizations) of patients hospitalized with a primary diagnosis of ACS is analyzed.",[13,14],"Other: medical chart review","Other: data generated by direct IT export",{"label":16,"type":10,"description":17,"interventionNames":18},"acute heart failure (AHF)","Outcome information (all-cause death, heart failure (HF) hospitalizations) of patients hospitalized with a primary or secondary diagnosis of AHF is analyzed.",[13,14],[20,24],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"medical chart review","data generated by medical review include Medical history, Medications at presentation, during hospitalization and at discharge, New York Heart Association (NYHA) class, Killip class, Electrocardiographic (ECG) data, echocardiographic data, Interventions (Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Graft (CABG), Implantable Cardioverter Defibrillator (ICD) implantation, Cardiac Resynchronization Therapy (CRT) Implantation), Outcome Information: all-cause death, HF hospitalizations",[9,16],{"type":6,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"data generated by direct IT export","data generated by direct IT export include Anthropometric data (age, sex, height, weight), Vital signs, Laboratory data",[9,16],[29],{"name":30,"affiliation":31,"role":32},"Christian Müller, Prof. Dr.","Cardiology University Hospital Basel","PRINCIPAL_INVESTIGATOR",[34,38],{"name":30,"role":35,"phone":36,"phoneExt":10,"email":37},"CONTACT","0041 6132 86 549","Christian.mueller@usb.ch",{"name":39,"role":35,"phone":40,"phoneExt":10,"email":41},"Fiona Nafaa, MD","+41 61 32 87747","fiona.nafaa@usb.ch",[43],{"facility":44,"status":45,"city":46,"state":10,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Cardiology, University Hospital Basel","RECRUITING","Basel","4031","Switzerland","CH",{"type":51,"coordinates":52},"Point",[53,54],7.57327,47.55839,{"lat":54,"lon":53},[57],{"name":58,"role":35,"phone":59,"phoneExt":10,"email":37},"Christian Mueller, Prof. Dr.","+41 61 32 86 549",{"type":61,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100362504","heart-failure-usb-prediction-and-progression-100362504",false,"NCT04000061","Heart Failure-USB: Prediction and Progression","Inclusion Criteria:\n\n* Patients hospitalized with a primary diagnosis of ACS\n* Patients hospitalized with a primary or secondary diagnosis of AHF\n\nExclusion Criteria:\n\n* Existence of a documented statement of the patient against the scientific use of clinical data","ALL","18 Years",{"count":71,"type":72},6000,"ESTIMATED","OBSERVATIONAL","This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and\u002F or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.",[76,77,78],"Acute Heart Failure","Acute Coronary Syndrome","Heart Failure","2025-04-09",{"date":81,"type":82},"2025-04-10","ACTUAL",{"date":84,"type":82},"2019-06-13",{"date":86,"type":72},"2026-12-31",{"name":5,"class":6},1]